Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients
JE Marfori, MM Exner, GI Marousek, S Chou… - Journal of clinical …, 2007 - Elsevier
BACKGROUND: We report on two allogeneic stem cell transplant recipients who developed
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.
JE Marfori, MM Exner, GI Marousek… - Journal of Clinical …, 2006 - europepmc.org
Background We report on two allogeneic stem cell transplant recipients who developed
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients
JE Marfori, MM Exner, GI Marousek… - Journal of Clinical …, 2007 - ohsu.elsevierpure.com
Background: We report on two allogeneic stem cell transplant recipients who developed
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients
JE Marfori, MM Exner, GI Marousek… - Journal of clinical …, 2007 - pubmed.ncbi.nlm.nih.gov
Background We report on two allogeneic stem cell transplant recipients who developed
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.
JE Marfori, MM Exner, GI Marousek, SW Chou… - 2007 - cabidigitallibrary.org
Background: We report on two allogeneic stem cell transplant recipients who developed
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
cytomegalovirus disease associated with new viral mutations that conferred antiviral drug …
Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients
JE Marfori, MM Exner, GI Marousek, S Chou… - Journal of Clinical …, 2007 - infona.pl
We report on two allogeneic stem cell transplant recipients who developed cytomegalovirus
disease associated with new viral mutations that conferred antiviral drug resistance. Blood …
disease associated with new viral mutations that conferred antiviral drug resistance. Blood …
[引用][C] Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell …
JE MARFORI, MM EXNER… - Journal of clinical …, 2007 - pascal-francis.inist.fr
Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug
resistance after valganciclovir therapy in allogeneic stem cell recipients CNRS Inist …
resistance after valganciclovir therapy in allogeneic stem cell recipients CNRS Inist …